vimarsana.com

Latest Breaking News On - Beta lactamase inhibitor - Page 1 : vimarsana.com

FDA issues CRL for Venatorx s antibiotic combo in UTIs

The good news is that the U.S. FDA’s complete response letter (CRL) for Venatorx Pharmaceuticals Inc.’s intravenous antibiotic combination, cefepime-taniborbactam, in complicated urinary tract infections (cUTIs) requested no additional clinical testing. The bad news is the inevitable delay for a drug Venatorx and partner Melinta Therapeutics Inc. are aiming to position as a much-needed option for the fight against drug-resistant gram-negative infections.

Orchid Pharma s Exblifep gets USFDA approval; stock surges - The Hindu BusinessLine

Orchid Pharma s Exblifep gets USFDA approval; stock surges - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Asia-Pacific Is Expected To Remain Dominant In The Global Beta-Lactam And Beta-Lactamase Inhibitors Market 2019 To 2028

Asia-Pacific Is Expected To Remain Dominant In The Global Beta-Lactam And Beta-Lactamase Inhibitors Market 2019 To 2028
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.